title: Utilization of next generation sequencing identifies potentially actionable mutations in chronic lymphocytic leukaemia.
authors.affiliation: Center for CLL, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
authors.forename: Jie
authors.initials: J
authors.lastname: Wang
authors.affiliation: Center for Personalized Diagnostics, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Morrissette
authors.affiliation: Center for Personalized Diagnostics, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
authors.forename: David B
authors.initials: DB
authors.lastname: Lieberman
authors.affiliation: Center for CLL, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
authors.forename: Colleen
authors.initials: C
authors.lastname: Timlin
authors.affiliation: Center for CLL, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Schuster
authors.affiliation: Center for CLL, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
authors.forename: Anthony R
authors.initials: AR
authors.lastname: Mato
mesh_terms: D014408:Biomarkers, Tumor; D056726:Genetic Association Studies; D020022:Genetic Predisposition to Disease; D023281:Genomics / Q000379:methods; D059014:High-Throughput Nucleotide Sequencing; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000235:genetics* / Q000378:metabolism; D009154:Mutation; D009857:Oncogenes
chemical_list: D014408:Biomarkers, Tumor
keywords: chronic lymphocytic leukaemia; mutation analysis; mutation detection